Key result
The P403A mutation in the Kv1.1 channel caused a loss-of-function phenotype with smaller potassium currents and shifted voltage-dependent activation (+30 mV), correlating with the clinical symptoms.
Why the study?
The study aimed to functionally characterize a de novo Kv1.1 mutant channel in the PVP motif to provide a genotype-phenotype correlation and discuss therapeutic options for KCNA1-related epilepsy.
Case Report (n=1)
The P403A mutation in the Kv1.1 channel causes a loss-of-function biophysical phenotype that correlates with severe epileptic symptoms, which may respond to acetazolamide and sodium channel blockers.
This is the authors' abstract. We don't add key points for this paper.
Mutations in the KCNA1 gene, encoding the voltage-gated potassium channel Kv1.1, have been associated with a spectrum of neurological phenotypes, including episodic ataxia type 1 and developmental and epileptic encephalopathy. We have recently identified a de novo variant in KCNA1 in the highly conserved Pro-Val-Pro motif within the pore of the Kv1.1 channel in a girl affected by early onset epilepsy, ataxia and developmental delay. Other mutations causing severe epilepsy are located in Kv1.1 pore domain. The patient was initially treated with a combination of antiepileptic drugs with limited benefit. Finally, seizures and ataxia control were achieved with lacosamide and acetazolamide. The aim of this study was to functionally characterize Kv1.1 mutant channel to provide a genotype–phenotype correlation and discuss therapeutic options for KCNA1-related epilepsy. To this aim, we transfected HEK 293 cells with Kv1.1 or P403A cDNAs and recorded potassium currents through whole-cell patch-clamp. P403A channels showed smaller potassium currents, voltage-dependent activation shifted by +30 mV towards positive potentials and slower kinetics of activation compared with Kv1.1 wild-type. Heteromeric Kv1.1+P403A channels, resembling the condition of the heterozygous patient, confirmed a loss-of-function biophysical phenotype. Overall, the functional characterization of P403A channels correlates with the clinical symptoms of the patient and supports the observation that mutations associated with severe epileptic phenotype cluster in a highly conserved stretch of residues in Kv1.1 pore domain. This study also strengthens the beneficial effect of acetazolamide and sodium channel blockers in KCNA1 channelopathies.
Answers are grounded in this paper and cite their sources.
Correlates Kv1.1 P403A loss-of-function with severe epilepsy in models; leaves open targeted therapies in patients.
No takes yet. Share an insight, caveat, or question.
Dinoi et al. (2022) conducted a case report in Epilepsy, developmental delay and ataxia (n=1). P403A mutation in KCNA1 vs. Wild-type Kv1.1 was evaluated on Potassium currents and channel activation kinetics. The P403A mutation in the Kv1.1 channel caused a loss-of-function phenotype with smaller potassium currents and shifted voltage-dependent activation (+30 mV), correlating with the clinical symptoms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: